Mitchell Chan Regenxbio Inc. (RGNX) insider trading activity

RGNX Quotes by TradingView

Mitchell Chan is Chief Financial Officer of REGENXBIO Inc.. Currently has a direct ownership of 127,717 shares of RGNX, which is worth approximately $1.47 Million. The most recent transaction as insider was on Jan 06, 2026, when has been sold 73,749 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 128K
136.65% 3M change
116.95% 12M change
Total Value Held $1.47 Million

Mitchell Chan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 06 2026
BUY
Grant, award, or other acquisition
-
73,749 Added 36.61%
127,717 Common Stock
Sep 01 2025
SELL
Payment of exercise price or tax liability
$43,765 $8.93 p/Share
4,901 Reduced 8.33%
53,968 Common Stock
Sep 16 2024
BUY
Grant, award, or other acquisition
-
58,869 Added 50.0%
58,869 Common Stock

Also insider at

VIE
Viela Bio, Inc.
Chief Financial Officer
AVTX
Avalo Therapeutics, Inc. Healthcare
Director
MC

Mitchell Chan

Chief Financial Officer
Gaithersburg, MD

Track Institutional and Insider Activities on RGNX

Follow REGENXBIO Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RGNX shares.

Notify only if

Insider Trading

Get notified when an Regenxbio Inc. insider buys or sells RGNX shares.

Notify only if

News

Receive news related to REGENXBIO Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RGNX